Projects per year
Search results
-
Finished
Intraperitoneal FT538 with Intravenous Enoblituzumab in Recurrent Ovarian, Fallopian Tube, and PrimaryPeritoneal Cancer
Geller, M. A. (PI)
5/1/22 → 12/31/23
Project: Research project
-
IL-15 superagonist ALT 803 maintenance therapy to prevent recurrence of advanced stage ovarian cancer
Geller, M. A. (PI) & De For, T. E. (Other Role)
8/1/20 → 7/31/22
Project: Research project
-
Intraperitoneal FATE FT516 and Interleukin-2 (IL-2) with Intravenous Enoblituzumab in Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
Geller, M. A. (PI)
7/20/20 → 8/23/23
Project: Research project
-
Manipulating the ovarian cancer tumor microenvironment to enhance natural killer (NK) cell killing
Geller, M. A. (PI) & Felices, M. (CoI)
7/1/20 → 6/30/24
Project: Research project
-
Clinical Precision Medicine Based on Single Cell Analysis
AbuSalah, A. M. (Collaborator), Aliferis, MD, PhD, C. (Collaborator), Beckman, K. B. (Collaborator), Bielinsky, A. K. (Collaborator), Chang, Z. (Collaborator), Geller, M. A. (Collaborator), Harris, R. (Collaborator), Khalifa, M. A. (Collaborator), Mullany, S. A. (Collaborator), Myers, C. L. (Collaborator), Nelson, A. C. (Collaborator), Schondelmeyer, S. W. (Collaborator), Shen, S. (Collaborator), Starr, T. (Collaborator), Talukdar, S. (Collaborator), Uppendahl, L. D. (Collaborator), Wang, J. (Collaborator), Winterhoff, B. J. (Collaborator) & Yee, D. (Collaborator)
1/1/19 → 1/31/21
Project: Grand Challenges
-
NCTN High Performing Site Initiative
Geller, M. A. (PI)
NIH NATIONAL CANCER INSTITUTE (NCI)
9/1/18 → 8/31/19
Project: Research project
-
Engineered natural killer cells expressing chimeric CD64
Walcheck, B. (PI), Geller, M. A. (CoI) & Wu, J. (CoI)
7/1/18 → 6/30/19
Project: Research project
-
IL-15 Superagonist ALT-803 for Treatment of Advanced Sta
Geller, M. A. (PI)
7/17/17 → 7/31/20
Project: Research project
-
Intraperitoneal Delivery of Adaptive Natural Killer (NK)
Geller, M. A. (PI)
7/1/17 → 7/30/22
Project: Research project
-
A phase III multicenter randomized study of atezolizumab
Geller, M. A. (PI)
6/1/17 → 3/31/25
Project: Research project
-
Clinical Trial Support Agreement
Geller, M. A. (PI) & Cooley, S. A. (Prior Principal Investigator)
5/1/17 → 12/31/20
Project: Research project
-
A Randomized Phase II/III study of the combination of Ce
Geller, M. A. (PI)
1/1/17 → 2/28/25
Project: Research project
-
Development of a clinical precision medicine program in ovarian cancer as a paradigm for 21st-century tailored healthcare solution
AbuSalah, A. M. (Collaborator), Aliferis, MD, PhD, C. (Collaborator), Argenta, P. A. (Collaborator), Baller, J. A. (Collaborator), Bazzaro, M. (Collaborator), Chang, Z. (Collaborator), Geller, M. A. (Collaborator), Jacobson, P. A. (Collaborator), Khalifa, M. A. (Collaborator), Mullany, S. A. (Collaborator), Nelson, A. C. (Collaborator), Shen, S. (Collaborator), Simon, G. J. (Collaborator), Starr, T. (Collaborator), Subramanian, S. (Collaborator), Uppendahl, L. D. (Collaborator) & Winterhoff, B. J. (Collaborator)
1/1/17 → 1/31/19
Project: Grand Challenges
-
GOG-286B A Randomized Phase I/II Study of Paclitaxel/Car
Geller, M. A. (PI)
1/1/17 → 12/31/20
Project: Research project
-
A Phase III study comparing single-agent olaparib or the
Geller, M. A. (PI)
NRG ONCOLOGY FOUNDATION, INC., NIH NATIONAL CANCER INSTITUTE (NCI)
10/1/16 → 2/28/25
Project: Research project
-
A Paradigm Shift for Ovarian Cancer Detection: Screening
Skubitz, A. P. (PI), Boylan, K. L. (CoI), Geller, M. A. (CoI), Griffin, T. J. (CoI), Khalifa, M. A. (Other Role) & de Jong, E. (Other Role)
US ARMY MED RESEARCH & MATERIEL COMMAND
8/1/16 → 1/31/20
Project: Research project
-
GOG-286B: A Randomized Phase II/III Study Of Paclitaxel/
Geller, M. A. (PI)
4/1/16 → 2/28/19
Project: Research project
-
Molecular analysis of endometrial hyperplasia, carcinoma
Geller, M. A. (PI)
11/1/15 → 10/31/16
Project: Research project
-
A Randomized, Double-blind, Placebo-Controlled, Phase 2
Geller, M. A. (PI)
3/9/15 → 12/31/21
Project: Research project
-
A Phase 2, Open-Label, Single-Arm Study to Evaluate the
Geller, M. A. (PI)
3/3/15 → 9/1/20
Project: Research project
-
Natural Killer Cell Immunotherapy for Ovarian Cancer
Geller, M. A. (PI) & Kaufman, D. S. (CoI)
1/1/15 → 12/31/19
Project: Research project
-
Discovery of ovarian cancer biomarkers in Pap test fluid
Skubitz, A. P. (PI), Geller, M. A. (CoI) & Griffin, T. J. (CoI)
1/1/15 → 12/31/15
Project: Research project
-
An open label Phase I dose escalation study to evaluate
Geller, M. A. (PI)
BAYER HEALTHCARE PHARMACEUTICALS
10/8/14 → 12/1/14
Project: Research project
-
Chimeric Antigen Receptor-Directed Therapy Against
Geller, M. A. (PI) & Kaufman, D. S. (Prior Principal Investigator)
9/1/14 → 8/31/17
Project: Research project
-
Verification of Ovarian Cancer Protein Biomarkers
Skubitz, A. P. (PI), Boylan, K. L. (CoI), Afiuni, S. (Other Role), Geller, M. A. (Other Role), Griffin, T. J. (Other Role), Vogel, R. (Other Role) & de Jong, E. (Other Role)
8/1/14 → 12/31/16
Project: Research project
-
Mobile Phone Technology to Increase Genetic Counseling
Geller, M. A. (PI) & Lee, H. Y. (CoI)
5/12/14 → 5/11/18
Project: Research project
-
Indoleamine-2,3-dioxygenase (IDO) Inhibition with INCB02
Geller, M. A. (PI) & Kaufman, D. S. (CoI)
5/1/14 → 2/28/17
Project: Research project
-
The National Myelodysplastic Syndromes Natural History S
Geller, M. A. (PI)
3/1/14 → 7/31/19
Project: Research project
-
RTOG-0815: A Phase III Prospective Randomized Trial of D
Geller, M. A. (PI)
3/1/14 → 7/31/19
Project: Research project
-
NRG-CC003: A Randomized Phase II/III Trial of Prophylact
Geller, M. A. (PI)
3/1/14 → 7/31/19
Project: Research project
-
A Randomized Phase III Trial of Adjuvant Therapy Compari
Geller, M. A. (PI)
3/1/14 → 7/31/19
Project: Research project
-
NRG-BN001: Randomized Phase II Trial of Hypofractionated
Geller, M. A. (PI)
3/1/14 → 7/31/19
Project: Research project
-
MASTER NRG Oncology Studies
Geller, M. A. (PI) & Teoh, D. G. (CoI)
NRG ONCOLOGY FOUNDATION, INC., NIH NATIONAL CANCER INSTITUTE (NCI)
3/1/14 → 7/31/19
Project: Research project
-
Detection of ovarian cancer biomarkers in Pap test fluid
Skubitz, A. P. (PI), Geller, M. A. (CoI), Griffin, T. J. (CoI) & Afiuni, S. (Other Role)
1/1/14 → 12/31/14
Project: Research project
-
A Phase 3 Randomized Double-blind Trial of Maintenance
Geller, M. A. (PI)
8/1/13 → 5/4/17
Project: Research project
-
Identification and validation of ovarian cancer protein
Skubitz, A. P. (PI), Geller, M. A. (CoI), Griffin, T. J. (CoI) & Afiuni, S. (Other Role)
8/1/13 → 1/31/15
Project: Research project
-
NK Cell Immunotherapy for Ovarian Cancer
Geller, M. A. (PI) & Kaufman, D. S. (CoI)
7/1/13 → 12/31/15
Project: Research project
-
Detection of ovarian cancer biomarkers in routine Pap te
Skubitz, A. P. (PI), Geller, M. A. (CoI), Griffin, T. J. (CoI), Pambuccian, S. (CoI) & Afiuni, S. (Other Role)
7/1/12 → 12/31/13
Project: Research project
-
Minnelide: A novel therapeutic agent for ovarian cancer
Geller, M. A. (PI), Ramakrishnan, S. (CoI) & Saluja, A. K. (CoI)
7/1/12 → 6/30/14
Project: Research project
-
Lymphodepleting Chemotherapy and T-Cell Suppression ...
Geller, M. A. (PI) & Miller, J. S. (Other Role)
11/1/11 → 10/31/14
Project: Research project
-
The Role of Proteasome Inhibition on Death Receptor Indu
Geller, M. A. (PI) & Miller, J. S. (Other Role)
3/1/11 → 2/28/13
Project: Research project
-
Sensitization of Ovarian Cancer to NK Cell-Mediated Kill
Geller, M. A. (PI) & Miller, J. S. (Other Role)
12/15/10 → 12/31/12
Project: Research project
-
Molecular Profiling to Predict Response to Chemotherapy
Geller, M. A. (PI) & Judson, P. (Prior Principal Investigator)
H. LEE MOFFITT CANCER CENTER & RESEARCH, NIH NATIONAL CANCER INSTITUTE (NCI)
4/1/10 → 7/31/13
Project: Research project
-
Sensitization of Ovarian Cancer to NK Cell-Mediated Kill
Geller, M. A. (PI) & Miller, J. S. (Other Role)
MAYO CLINIC ROCHESTER, NATIONAL INSTITUTES OF HEALTH (NIH)
12/1/09 → 6/30/11
Project: Research project
-
IL-2 Stimulated Allogeneic NK Cells in an In Vivo Ovaria
Geller, M. A. (PI)
11/1/08 → 10/31/10
Project: Research project
-
MCP-1 (Monocyte Chemotactic Protein-1) Levels in Patient
Geller, M. A. (PI)
10/1/05 → 3/30/08
Project: Research project
-
A Phase II Trial of Induction Carboplatin & Docetaxel Fo
Geller, M. A. (PI)
7/29/04 → 6/1/10
Project: Research project